Literature DB >> 7875787

Simple predictors to differentiate acute asthma from ARI in children: implications for refining case management in the ARI Control Programme.

H P Sachdev1, B Vasanthi, L Satyanarayana, R K Puri.   

Abstract

There is a considerable overlap in the clinical presentation of acute asthma and ARI. According to the current ARI Control Programme recommendations, a child with cough and rapid breathing is overtreated for ARI (pneumonia) with antibiotics and undertreated for asthma with bronchodilators. The present study, therefore, evaluated simple predictors to differentiate these two conditions to refine the recommended case management. In a case control comparison, children between 6 to 60 months age who presented with cough and rapid breathing due to acute asthma (n = 100) and ARI (n = 100) were evaluated. Only 34% of asthmatics had an audible wheeze. Significant independent predictors on multiple logistic regression analysis were number of earlier similar attacks and fever (or temperature). The best predictor for asthma was two or more earlier similar episodes (sensitivity 84%, specificity 84%) followed by temperature < 37.6 degrees C (sensitivity 73% and specificity 84%). Absence of fever, audible wheeze and a family history of asthma had excellent specificities (98-100%) but low sensitivities (20-34%). It is concluded that simple clinical predictors can differentiate acute asthma and ARI. The recommended case management can, therefore, be refined by either: (i) Prescribing bronchodilators and no antibiotics with two or more earlier similar episodes of cough and rapid breathing; or (ii) To further minimize undertreatment for pneumonia, prescribing bronchodilators as above, but denying antibiotics in such cases only if there is audible wheeze or family history of asthma or no fever.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7875787

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  7 in total

1.  Redefining the World Health Organization algorithm for diagnosis of pneumonia with simple additional markers.

Authors:  M R Savitha; Jagadish B Khanagavi
Journal:  Indian J Pediatr       Date:  2008-08-31       Impact factor: 1.967

2.  Childhood asthma in low income countries: an invisible killer?

Authors:  Marianne Stubbe Østergaard; Rebecca Nantanda; James K Tumwine; Rune Aabenhus
Journal:  Prim Care Respir J       Date:  2012-06

3.  Assessment and management of children aged 1-59 months presenting with wheeze, fast breathing, and/or lower chest indrawing; results of a multicentre descriptive study in Pakistan.

Authors:  T Hazir; S Qazi; Y B Nisar; S Ansari; S Maqbool; S Randhawa; Z Kundi; R Asghar; S Aslam
Journal:  Arch Dis Child       Date:  2004-11       Impact factor: 3.791

4.  Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.

Authors:  Tabish Hazir; Shamim A Qazi; Yasir Bin Nisar; Sajid Maqbool; Rai Asghar; Imran Iqbal; Sobia Khalid; Sajid Randhawa; Shazia Aslam; Sobia Riaz; Saleem Abbasi
Journal:  Arch Dis Child       Date:  2006-03-17       Impact factor: 3.791

5.  Asthma and pneumonia among children less than five years with acute respiratory symptoms in Mulago Hospital, Uganda: evidence of under-diagnosis of asthma.

Authors:  Rebecca Nantanda; James K Tumwine; Grace Ndeezi; Marianne S Ostergaard
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

6.  Virome and bacteriome characterization of children with pneumonia and asthma in Mexico City during winter seasons 2014 and 2015.

Authors:  Jose A Romero-Espinoza; Yazmin Moreno-Valencia; Rodrigo H Coronel-Tellez; Manuel Castillejos-Lopez; Andres Hernandez; Aaron Dominguez; Angel Miliar-Garcia; Arturo Barbachano-Guerrero; Rogelio Perez-Padilla; Alejandro Alejandre-Garcia; Joel A Vazquez-Perez
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

7.  Symptom-based screening tool for asthma syndrome among young children in Uganda.

Authors:  Rebecca Nantanda; Volkert Siersma; Grace Ndeezi; James K Tumwine; Marianne S Østergaard
Journal:  NPJ Prim Care Respir Med       Date:  2020-05-06       Impact factor: 2.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.